July 30, 2014 9:40 PM ET

Pharmaceuticals

Company Overview of Teva Pharmaceuticals USA, Inc.

Company Overview

Teva Pharmaceuticals USA, Inc. develops, manufactures, and supplies generic prescription medications in the United States. It offers various therapeutic medications in the areas of cardiovascular, anti-infective, central nervous system, anti-inflammatory, oncolytic, anti-diabetic, analgesic, dermatologic, respiratory, and women's health, as well as provides oncology products and latex-free products. The company offers its products in various dosage forms, such as tablets, capsules, injectables, creams, ointments, inhalants, solutions, and suspensions. It serves patients through distributors. Teva Pharmaceuticals USA, Inc. was formerly known as Lemmon Pharmacal Company and changed its name to...

1090 Horsham Road

North Wales, PA 19454

United States

Founded in 1945

Phone:

215-591-3000

Fax:

215-591-8600

Key Executives for Teva Pharmaceuticals USA, Inc.

Chief Executive Officer of Teva North America and President of Teva North America
Age: 66
Vice President of Government Affairs
Vice President of Government Affairs
Vice President of Government Affairs
Vice President of Government Affairs
Compensation as of Fiscal Year 2014.

Teva Pharmaceuticals USA, Inc. Key Developments

Teva Pharmaceuticals USA, Inc. Settles Patent Litigation with Pfizer on Celebrex(R)

Teva Pharmaceuticals USA, Inc. has entered into a settlement with Pfizer related to Teva's generic version of Celebrex(R) (celecoxib) 50, 100, 200 and 400 mg capsules in the United States. Under the terms of the settlement, Teva may launch its generic versions in December, 2014, or earlier under certain circumstances. Teva has received tentative approval from the U.S. Food and Drug Administration (FDA) for all strengths and believes that it is first-to-file on at least the 100, 200 and 400 mg capsules. Sales of Celebrex(R) were $2.2 billion in the U.S. according to IMS data as of December, 2013.

Teva Pharmaceuticals USA, Inc. Presents at Latin America & Caribbean Life Sciences Conference, Mar-28-2014 10:45 AM

Teva Pharmaceuticals USA, Inc. Presents at Latin America & Caribbean Life Sciences Conference, Mar-28-2014 10:45 AM. Venue: Graham Center Ballroom, FIU-Maidique Campus, Miami, Florida, United States. Speakers: Michelle Cuccia, Vice President for Commercial Operations, Latin America.

Teva Pharmaceuticals USA, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-23-2014 02:00 PM

Teva Pharmaceuticals USA, Inc. Presents at 9th Annual The Neurotech Investing & Partnering Conference 2014, Apr-23-2014 02:00 PM. Venue: The Ritz Carlton, 10 Avery St., Boston, Massachusetts, United States. Speakers: Rivka Riven Kreitman, Senior VP, Head of Search, Evaluation & Alliance Management.

Similar Private Companies By Industry

Company Name Region
Morton Grove Pharmaceuticals, Inc. United States
Great HealthWorks Inc. United States
Traditional Medicinals, Inc. United States
Scholar Rock, LLC United States
MeriCal, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 26, 2013
Teva Pharmaceutical Industries Limited, 31 Generic Drug Products
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Teva Pharmaceuticals USA, Inc., please visit www.tevagenerics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.